NCT03979209View on ClinicalTrials.gov

Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

June 22, 2021

Study Completion Date

July 28, 2022

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

Nasal Mometasone Rinse

Nasal irrigation twice a day (BID) of assigned dose.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

Advanced Rx
All Listed Sponsors
collaborator

Advanced Rx

INDUSTRY

lead

Rush University Medical Center

OTHER

NCT03979209 - Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages. | Biotech Hunter | Biotech Hunter